Chih-Chi Chou
Overview
Explore the profile of Chih-Chi Chou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
61
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheng L, Su P, Kuo M, Lin C, Luo H, Chou C, et al.
Ther Adv Med Oncol
. 2024 Dec;
16:17588359241305091.
PMID: 39687055
Background: Despite the revolutionary impact of immune checkpoint inhibitors (ICIs) on the treatment of metastatic urothelial carcinoma (mUC), the clinical utility of reliable prognostic biomarkers to foresee survival outcomes remains...
2.
Huang S, Su P, Lin C, Kuo M, Chen Y, Wu C, et al.
Cancer Med
. 2024 Feb;
13(2):e7008.
PMID: 38334504
Background: Studies on the correlation between high body mass index (BMI) and extended survival among patients receiving immune checkpoint inhibitors (ICIs) have been made, although findings have shown variability. Our...
3.
Tsai T, Su P, Huang S, Kuo M, Lin C, Wu C, et al.
BMC Cancer
. 2023 Sep;
23(1):871.
PMID: 37715113
Background: While the treatment guidelines have been established for pure urothelial carcinoma (pUC), patients with variant type urothelial carcinoma (vUC) face limited effective treatment options. The effectiveness of immune checkpoint...
4.
Liu H, Weng S, Chou C, You H, Wang M, Ma M, et al.
J Clin Pathol
. 2023 Aug;
77(11):743-750.
PMID: 37620127
Aims: Angioimmunoblastic T cell lymphoma (AITL) is a T cell lymphoma with aberrant immune activity. It is characterised by inflammatory and immune reactions. However, the impact of regulatory T (Treg)...
5.
Liu H, Liao C, Weng S, Shih L, Chou C, You H, et al.
Pathobiology
. 2022 Nov;
90(3):187-198.
PMID: 36423589
Introduction: Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive T-cell lymphoma commonly associated with B-cell dysregulation. Correlations involving B-cell dysregulation and clinicopathological features remain unclear. Methods: We prospectively collected blood samples...
6.
Chen C, Chu T, Chou C, Chien C, Wang J, Huang C
Oral Oncol
. 2021 Jun;
120:105402.
PMID: 34174519
Objectives: microRNA (miRNA) expression patterns have provided new insight as biomarkers of prognosis as well as novel therapeutic targets for several neoplasms. However, the role of exosomal miRNA in the...
7.
Chou C, Tsao C, Liao C, You H, Wang M, Huang W
Exp Mol Pathol
. 2020 Nov;
118:104577.
PMID: 33242451
Extranodal nasal-type natural killer (NK)/T-cell lymphoma (NKTCL) is an aggressive lymphoma that is prevalent among East Asian and South American populations. Although Epstein-Barr virus (EBV) is commonly detected in NKTCL,...
8.
Ho C, Lin H, Chou C, Huang H
Ear Nose Throat J
. 2019 Jul;
99(10):NP109-NP110.
PMID: 31272210
No abstract available.
9.
Hsiao H, Chen R, Chou C, Cheng T
Sensors (Basel)
. 2019 Apr;
19(7).
PMID: 30939788
This study develops a hand-held stress assessment meter with a chemically colorimetric strip for determining salivary α-amylase activity, using a 3,5 dinitrosalicylic acid (DNS) assay to quantify the reducing sugar...
10.
Lin P, Lin J, Lin C, Lin H, Yang S, Jiang J, et al.
Ann Surg Oncol
. 2014 Dec;
22 Suppl 3:S1419-27.
PMID: 25472652
Background: DNA methylation is a potential tumor marker for several cancers, including colorectal cancer (CRC), because of its heritable and stable characteristics. Methods: Using a high-resolution, genome-wide approach, we epigenotyped...